| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 25 Apr 2025 | 18 Apr 2025 |
| Dr. Lal Pathlabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/04/2025 inter alia to consider and approve the Audited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Financial Year ended March 31 2025 and to consider recommending Final Dividend if any on the Equity Shares of the Company for the Financial Year ended March 31 2025. Attached Recommendation of final dividend of INR 6/- per equity share (@ 60% on a face value of INR 10/- each) for the financial year ended March 31, 2025, subject to approval of the Members of the Company at ensuing Annual General Meeting (AGM). The record date for the purpose of payment of final dividend shall be June 06, 2025. The Final Dividend will be dispatched/ credited within 30 days of the approval by the Members. (As Per BSE Announcement Dated on 25.04.2025) | ||
| Board Meeting | 30 Jan 2025 | 23 Jan 2025 |
| Dr. Lal Pathlabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2025 inter alia to consider and approve Unaudited (Standalone and Consolidated) Financial Results for the quarter and nine months ended 31-12-2024 and to consider the proposal for declaration of 3rd interim dividend if any for the financial year 2024-2025 Attached Approved declaration of 3rd Interim Dividend of INR 6/- per equity share (@ 60% on a face value of INR 10/- each) for the FY 2024-25. The record date for the purpose of payment of 3 rd Interim Dividend shall be February 05, 2025. The 3rd Interim Dividend will be dispatched/ credited within 30 days of the declaration. (As per BSE Announcement Dated on 30/01/2025) | ||
| Board Meeting | 23 Oct 2024 | 16 Oct 2024 |
| Dr. Lal Pathlabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2024 inter alia to consider and approve the Un-audited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Half Year ended 30-09-2024 and to consider the proposal of declaration of 2nd Interim Dividend if any on the Equity Shares of the Company for the Financial Year 2024-25. Attached (As Per BSE Announcement Dated on 23.10.2024) | ||
| Board Meeting | 13 Aug 2024 | 13 Aug 2024 |
| Outcome of Board Meeting dated Aug 13, 2024 | ||
| Board Meeting | 7 Aug 2024 | 31 Jul 2024 |
| Dr. Lal Pathlabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2024 inter alia to consider and approve Un-audited (Standalone & Consolidated) Financial Results of the Company for the Quarter ended June 30 2024 and to consider recommending Interim Dividend if any on the Equity Shares of the Company for the Financial Year 2024-25. Outcome of Board Meeting held on August 7, 2024 Declaration of Interim Dividend of INR 6/- per equity share (@ 60% on a face value of INR 10/- each) for the financial year 2024-25. The record date for the purpose of payment of Interim Dividend shall be August 20, 2024. The Interim Dividend will be dispatched/ credited within 30 days of its declaration. Results for quarter ended June 30, 2024 (As Per BSE Announcement Dated on 07.08.2024) | ||
| Board Meeting | 10 May 2024 | 3 May 2024 |
| Dr. Lal Pathlabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2024 inter alia to consider and approve the Audited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Financial year ended March 31 2024 and to consider recommending Final Dividend if any Outcome of Board Meeting (As Per BSE Announcement Dated on 10.05.2024) | ||
Dr Lal PathLabs declared a fourth interim dividend of ₹6 per share for 2025, reflecting its strong cash generation and shareholder remittance focus.
The company declared a third interim dividend of ₹6 per share (60% on a face value of ₹10) for FY25.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
